ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 308

Crepitus As a Risk Factor for Symptomatic Knee Osteoarthritis: Data from the Osteoarthritis Initiative

Grace H. Lo1, Michael T. Strayhorn2, Jeffrey B. Driban3, Lori Lyn Price4, Charles Eaton5 and Timothy E. McAlindon6, 1Immunology, Allergy, Rheumatology, Baylor College of Medicine, Houston, TX, 2VA HSR&D Center for Innovations in Quality, Effectiveness and Safety; Department of Medicine, Michael E. DeBakey VA Medical Center, Baylor College of Medicine, Houston, TX, 3Rheumatology, Tufts Medical Center, Boston, MA, 4Clinical Care Research, Tufts Medical Center, Boston, MA, 5Brown University, Providence, RI, 6Division of Rheumatology, Tufts Medical Center, Boston, MA

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: OA and osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2016

Title: Osteoarthritis – Clinical Aspects - Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Incident symptomatic OA is a common outcome of interest in epidemiologic studies of risk factors for OA.  We postulate that evaluating this outcome in those who do have radiographic OA (ROA) at baseline but do not have frequent knee symptoms will be more informative than the other at-risk groups.  Crepitus is the complaint of hearing         grating, cracking or popping sounds in and/or around a joint.  This is a common symptom in the clinical setting and is possibly predictive of incident knee OA.  Our purpose was to evaluate whether the association between crepitus and incident knee symptomatic osteoarthritis (SOA) is better detected in a group with ROA but without frequent knee symptoms than other at-risk groups.

Methods: This was a person-based longitudinal study using data from the Osteoarthritis Initiative (OAI).  We evaluated the right knee only and specifically focused on people at baseline without SOA.  Crepitus was assessed using the Knee injury and Osteoarthritis Outcome Score (KOOS) questionnaire at baseline.  PA semi-flexed knee radiographs and frequent knee pain (“During the past 12 months, have you had pain, aching, or stiffness in or around your right knee on most days for at least one month?  By most days, we mean more than half the days of a month” were assessed at baseline and 48-month visits.) were assessed at baseline and 48-month visits. ROA was defined as Kellgren and Lawrence (KL) grade ≥ 2.  We performed logistic regression with crepitus as the predictor and incident SOA by the 48 month visit as the outcome.  Subgroup analyses were performed by three groupings: (1) +ROA, –Sx:  those with ROA, but no frequent symptoms at baseline, (2) –ROA, +Sx: with frequent symptoms but no ROA at baseline, and (3) -ROA, –Sx without ROA or frequent symptoms at baseline.

Results: 2936 people each contributed one observation with a mean age of 61.1 (9.3) years and mean BMI of 28.2 (4.7) kg/m².  42% were male.  Incident SOA was least common in knees that never had crepitus and most common in those who always had crepitus (p for trend <0.0001) (Table 1). More than 75% of incident SOA cases originated from the +ROA, –Sx subgroup, despite it constituting about a third of the total number of observations.

Conclusion: Subjective knee crepitus strongly predicts incident SOA over 4 years.  Crepitus evaluated as a subjective assessment, therefore offers utility for identification of at-risk individuals, predictive modeling, and future research.  Selecting those with ROA but without frequent knee symptoms, may optimally power studies to evaluate incident SOA.  TABLES

Table 1. Overall association of crepitus with incident tibiofemoral SOA.
Incident SOA Unadjusted Odds Ratio for Incident SOA Adjusted Odds Ratio for Incident SOA*
All those without SOA at baseline n = 2936 people Total cases = 349
Crepitus Frequency Never 178/1851 (9.6%) Ref Ref
Rarely 49/332 (14.8%) 1.6 (1.2 – 2.3) 1.6 (1.1 – 2.3)
Sometimes 66/463 (14.3%) 1.6 (1.1 – 2.1) 1.7 (1.2 – 2.3)
Often 36/199 (18.1%) 2.1 (1.4 – 3.1) 2.2 (1.5 – 3.3)
Always 20/91 (22.0%) 2.6 (1.6 – 4.4) 3.2 (1.9 – 5.5)
p for trend < 0.0001 p for trend < 0.0001
*adjusted for age, sex, and BMI.
Table 2. Subgroup associations of crepitus with incident tibiofemoral SOA. 
Incident SOA Unadjusted Odds Ratio for Incident SOA Adjusted Odds Ratio for Incident SOA*
People with ROA but without symptoms at baseline. (+ROA, –Sx) n = 926 people Total cases = 265
Never 142/565 (25.1%) Ref Ref
Rarely 35/111 (31.5%) 1.4 (0.9 – 2.1) 1.3 (0.9 – 2.1)
Sometimes 44/145 (30.3%) 1.3 (0.9 – 1.9) 1.2 (0.8 – 1.9)
Often 29/68 (42.6%) 2.2 (1.3 – 3.7) 2.1 (1.2 – 3.5)
Always 15/37 (40.5%) 2.0 (1.0 – 4.0) 2.0 (1.0 – 3.9)
p for trend < 0.0001 p for trend = 0.03
People without ROA but with symptoms at baseline. (-ROA, +Sx) n = 529 people Total Cases = 41
Never 12/246 (4.9%) Ref Ref
Rarely 5/53 (9.4%) 2.0 (0.7 – 6.0) 2.0 (0.7 – 6.2)
Sometimes 13/133 (9.8%) 2.1 (0.9 – 4.8) 2.2 (0.9 – 5.0)
Often 6/60 (10.0%) 2.2 (0.8 – 6.0) 2.2 (0.8 – 6.4)
Always 5/37 (13.5%) 3.0 (1.0 – 9.2) 3.5 (1.1 – 11.3)
p for trend < 0.0001 p for trend < 0.0001
People without ROA and symptoms at baseline (-ROA, –Sx) n = 1467 people Total Cases = 43
Never 24/1032 (2.3%) Ref Ref
Rarely 9/165 (5.5%) 2.4 (1.1 – 5.3) 2.4 (1.1 – 5.4)
Sometimes 9/183 (4.9%) 2.1 (1.0 – 4.8) 2.2 (1.0 – 5.0)
Often 1/70 (1.4%) 0.5 (0.1 – 3.7) 0.5 (0.1 – 3.8)
Always 0/17 (0.0%) ** **
p for trend=0.3 p for trend =0.3
*adjusted for age, sex, and BMI. **In this set of analyses, because the “Always” group had 0 events, we collapsed the “Often and Always” groups into the same group.

Disclosure: G. H. Lo, NIH, 2; M. T. Strayhorn, None; J. B. Driban, None; L. L. Price, NIH, 2; C. Eaton, NIH, 2; T. E. McAlindon, NIH, 2.

To cite this abstract in AMA style:

Lo GH, Strayhorn MT, Driban JB, Price LL, Eaton C, McAlindon TE. Crepitus As a Risk Factor for Symptomatic Knee Osteoarthritis: Data from the Osteoarthritis Initiative [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/crepitus-as-a-risk-factor-for-symptomatic-knee-osteoarthritis-data-from-the-osteoarthritis-initiative/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/crepitus-as-a-risk-factor-for-symptomatic-knee-osteoarthritis-data-from-the-osteoarthritis-initiative/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology